3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
53
Ovarian Neoplasms
4
Prostatic Neoplasms
3
Neoplasms
3
Inflammatory Breast Neoplasms
3
HER2-positive Breast Cancer
3
Carcinoma, Non-Small-Cell Lung
3
Stomach Neoplasms
2
Solid Tumor
2
Rectal Neoplasms
2
Neoplasm Metastasis
2
Colonic Neoplasms
2
Urinary Bladder Neoplasms
1
Solid Cancers
1
Patient Preference
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors
1
Neuroblastoma
1
Neoplasms, Unknown Primary
1
Multiple Endocrine Neoplasia
1
Malignant Solid Neoplasm
1
Lung Neoplasms
1
Locally Advanced Breast Cancer
1
Her2-Positive Breast Cancer
1
HER2-positive Metastatic Breast Cancer
1
HER2-positive Early Breast Cancer
1
HER2-Positive Early Breast Cancer
1
HER2 Positive Breast Cancer
1
Fallopian Tube Neoplasms
1
Colorectal Neoplasms
1
Interventions
Radiotherapy
22
Fluorouracil
20
Oxaliplatin
19
Leucovorin
14
Cisplatin
14
Paclitaxel
10
Radiation
8
Irinotecan
8
Docetaxel
7
Capecitabine
7
Cetuximab
6
Carboplatin
6
pembrolizumab
5
Neoadjuvant Therapy
5
Trastuzumab
4
Taxes
4
Chemotherapy, Adjuvant
4
Panitumumab
3
Microarray Analysis
3
Immunohistochemistry
3
Folfox protocol
3
Epirubicin
3
Biopsy
3
tucatinib
2
Surgical Procedures, Operative
2
Reverse Transcriptase Polymerase Chain Reaction
2
Magnetic Resonance Spectroscopy
2
Gene Expression Profiling
2
Gefitinib
2
Everolimus
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adenocarcinoma Of Esophagus
×
pertuzumab
×
Clear all
No trials found.